← Back to AVBP Overview
ArriVent BioPharma, Inc. Common Stock (AVBP)
Profitability & Net Margin History
Current Net Margin
—
ArriVent BioPharma, Inc. Common Stock currently has a net profit margin of —.
Financial Fundamentals
AVBP • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.00 | -0.04 | — | — |
| 2025-09-30 | 0.00 | -0.03 | — | — |
| 2025-06-30 | 0.00 | -0.03 | — | — |
| 2025-03-31 | 0.00 | -0.06 | — | — |
| 2024-12-31 | 0.00 | -0.02 | — | — |
| 2024-09-30 | 0.00 | -0.02 | — | — |
| 2024-06-30 | 0.00 | -0.02 | — | — |
| 2024-03-31 | 0.00 | -0.02 | — | — |
| 2023-12-31 | 0.00 | -0.02 | — | — |
| 2023-09-30 | 0.00 | -0.01 | — | — |
| 2023-06-30 | 0.00 | -0.02 | — | — |
| 2023-03-31 | 0.00 | -0.01 | — | — |
| 2022-12-31 | 0.00 | -0.01 | — | — |
| 2022-09-30 | 0.00 | -0.01 | — | — |
| 2022-06-30 | 0.00 | -0.01 | — | — |
| 2022-03-31 | 0.00 | -0.01 | — | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.